VARIABLE CONVALESCENCE AND THERAPY AFTER CADAVERIC RENAL-TRANSPLANTATION UNDER CYCLOSPORIN-A AND STEROIDS
- 1 January 1982
- journal article
- research article
- Vol. 154 (6) , 819-825
Abstract
The postoperative convalescence period was analyzed for 42 consecutive patients who had cadaveric renal transplantation under therapy with cyclosporin A and steroids. Of the patients, 22 underwent transplantation for the 1st time and 20 had retransplantation. None of the recipients died. With a follow-up period of 2-8 mo., the survival rate of grafts is 96% after 1st transplantation and 85% after retransplantation. Immunosuppression with a standard regimen was used for all patients at the ontset. Early convalescence was highly variable, often necessitating adjustments of cyclosporin A and steroid dosage to accommodate the possibilities of rejection or cyclosporin A nephrotoxicity, or both, simultaneously. Management problems were more frequent and complex in patients undergoing retransplantation. A classification of convalescence patterns was evolved, with recommendations about how standardized initial therapy should be adjusted if the renal graft does not function promptly or deteriorates later.This publication has 15 references indexed in Scilit:
- IMMUNOPHARMACOLOGICAL MONITORING OF CYCLOSPORIN A-TREATED RECIPIENTS OF CADAVERIC KIDNEY ALLOGRAFTSTransplantation, 1982
- 99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A.Radiology, 1982
- Cyclosporin A in cadaveric organ transplantation.BMJ, 1981
- IMMUNOLOGICAL AND PHARMACOLOGICAL MONITORING IN THE CLINICAL USE OF CYCLOSPORIN AThe Lancet, 1981
- NEPHROTOXICITY OF CYCLOSPORIN A IN LIVER AND KIDNEY TRANSPLANT PATIENTSThe Lancet, 1981
- CYCLOSPORIN A FOR THE OLIGURIC RENAL TRANSPLANT PATIENTThe Lancet, 1981
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- THE USE OF CYCLOSPORIN-A AND PREDNISONE IN CADAVER KIDNEY-TRANSPLANTATION1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- 100 SECOND RENAL ALLOGRAFTS FROM A SINGLE TRANSPLANTATION INSTITUTIONTransplantation, 1979